Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Zimmer Biomet Holdings, Inc. (ZBH) had Revenue of $2.24B for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$2.24B
Net Income	$139.40M
Cost of Goods Sold	$792.40M
Gross Profit	$1.45B
Operating Expenses	$2.09B
Operating Income	$154.50M
Non-Operating Income/Expense	$-56.50M
Pre-Tax Income	$98.00M
Normalized Pre-Tax Income	$98.00M
Income after Taxes	$138.00M
Income from Continuous Operations	$138.00M
Consolidated Net Income/Loss	$137.90M
Normalized Income after Taxes	$138.00M
EBIT	$154.50M
EBITDA	$438.50M
Weighted-Average Shares Outstanding (Basic)	198.00M
Weighted-Average Shares Outstanding (Diluted)	198.70M
Earnings per Share (EPS) (Basic)	$0.70
Earnings per Share (EPS) (Diluted)	$0.71
Balance Sheet Financials
Current Assets	$5.12B
Property, Plant, and Equipment	$2.21B
Long-Term Assets	$17.97B
Total Assets	$23.09B
Current Liabilities	$2.58B
Long-Term Debt	$6.93B
Long-Term Liabilities	$7.80B
Total Liabilities	$10.39B
Common Equity	$12.71B
Tangible Shareholders Equity	$-1.96B
Shareholders Equity	$12.71B
Common Shares Outstanding	195.50M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.70B
Cash Flow from Investing Activities	$-1.98B
Cash Flow from Financial Activities	$326.00M
Beginning Cash	$525.50M
End Cash	$591.90M
Increase/Decrease in Cash	$66.40M
Stock-Based Compensation	$90.20M
Common Stock Dividends Paid	$-190.30M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.98
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.35
Debt to Equity Ratio	0.59
Gross Margin	64.68%
Operating Margin	6.89%
EBIT Margin	6.89%
EBITDA Margin	--
Pre-Tax Profit Margin	4.37%
Profit Margin	6.21%
Free Cash Flow	$1.17B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.35
Receiveable Turnover	1.32
Days Sales in Receivables	68.37
Return on Equity	1.09%
Return on Tangible Equity	-7.05%
Return on Assets	0.60%
Return on Investments	0.70%
Book Value Per Share	$64.99
Free Cash Flow per Share	$5.90
Operating Cash Flow per Share	$8.54

Data from Zacks Investment Research, Inc.